Silicon Valley Capital Partners
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1673633
SAN JOSE, CA
Position in REGN
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$3,090
+$3 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Silicon Valley Capital Partners holds $7,195 across 6 Biotechnology names. REGN ranks #2 (42.9% of the industry book) .
All Filings in REGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,090 | 4 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $3,087 | 4 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,249 | 4 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,100 | 4 | Shares | Sole | 2025-09-11 | |
| 2025-03-31 | $2,536 | 4 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $2,849 | 4 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||